Encompass Health Corp·4

Apr 16, 2:51 PM ET

CARMICHAEL GREG D 4

4 · Encompass Health Corp · Filed Apr 16, 2026

Research Summary

AI-generated summary of this filing

Updated

Encompass Health (EHC) Director Greg Carmichael Receives Award

What Happened

  • Greg D. Carmichael, a director of Encompass Health Corp (EHC), was granted 27 restricted stock units (RSUs) on 2026-04-15. The award is reported as an "A" (award/acquisition) at $0.00 per share (standard for RSU grants). Using the closing price on the dividend payment date ($105.24), the economic value of the 27 RSUs is about $2,841.48.
  • This was a dividend‑equivalent RSU credit (routine non‑employee director compensation), not a market purchase or sale — typically not a strong bullish/sell signal.

Key Details

  • Transaction date: 2026-04-15; Form 4 filed: 2026-04-16 (timely).
  • Transaction type/code: Award (A) — 27 RSUs granted at $0.00 per share.
  • Implied market value: 27 × $105.24 = ~$2,841.48 (based on closing price used to calculate the award).
  • Footnote: RSUs were credited in connection with a $0.19 per‑share cash dividend; the number of RSUs is calculated using the dividend amount and the closing price on the dividend payment date.
  • Shares owned after the transaction: not specified in the provided filing excerpt.

Context

  • These RSUs are dividend‑equivalent awards to non‑employee directors and are routine compensation rather than a direct purchase or sale of stock. Such awards are common and generally reflect standard director pay practices, not necessarily insider sentiment about future share performance.

Insider Transaction Report

Form 4
Period: 2026-04-15
Transactions
  • Award

    Encompass Health Common Stock

    [F1]
    2026-04-15+2718,686 total
Footnotes (1)
  • [F1]Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $105.24. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.
Signature
/s/ Patrick Darby, attorney-in-fact for Greg D. Carmichael|2026-04-16

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT